Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06870136 · ClinicalTrials.gov registry record
Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health
A clinical trial of Cognitive Decline, sponsored by M2 Ingredients.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06870136 is a study of Cognitive Decline that is actively recruiting participants, run by M2 Ingredients. The registered enrollment target is 150 participants, below the 1,147-participant average among 61 other Cognitive Decline trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06870136, a study of Cognitive Decline, is actively recruiting participants, sponsored by M2 Ingredients.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The rationale for this study is to observe differences in cognitive health outcomes such as short term memory and simple reaction time between a consumer-grade and commercially available Lion's mane mushroom product and a placebo control group. Additionally, the study aims to evaluate the impact of the product on cognitive function, mood, focus, motivation, sleep quality, and stress. A consumer-driven, decentralized observational clinical research study is therefore well-suited for evaluating the impact of this product in this population. The study will evaluate cognitive health outcomes in a broad age-range of adults who have chosen to try this product. The study will incorporate memory and cognitive function tests, participant reported outcome questionnaires and surveys. There is no "doctor-patient" relationship as part of this research since the participant as a consumer is making the informed choice to take the product and participate in the observational process with self-reported measures that can be done at home. Findings from this study will contribute knowledge toward the functional mushrooms and cognitive health and the design of future studies.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Lion's Mane Study Product
Study Locations (1)
California
- People Science - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-02-21 |
| Est. Completion | 2025-09-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06870136
The ClinicalTrials.gov registry entry for NCT06870136 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,147-participant average among 61 other Cognitive Decline trials with a reported enrollment target (87% lower). The listed sponsor is M2 Ingredients, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which Lion's Mane Study Product is the first listed.
NCT06870136 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06870136 about?
NCT06870136 is a clinical study titled "Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health". The rationale for this study is to observe differences in cognitive health outcomes such as short term memory and simple reaction time between a consumer-grade and commercially available Lion's mane mushroom product and a placebo control group. Additionally, the study aims to evaluate the impact of ...
What is the current status of trial NCT06870136?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-02-21. Estimated completion is 2025-09-17.
What conditions does trial NCT06870136 study?
This clinical trial studies the following conditions: Cognitive Decline.
What interventions are being tested in trial NCT06870136?
The interventions under investigation include: Lion's Mane Study Product (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06870136?
This trial is sponsored by M2 Ingredients, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06870136 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Older Breast Cancer Patients: Risk for Cognitive Decline
RECRUITING
-
Biomarker Exploration in Aging, Cognition and Neurodegeneration
RECRUITING · Phase 3
-
Glucose Variability and Cognition in Prediabetes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.